| Dr Steven M Murphey, MD | |
|
5000 W 4th St, Hattiesburg, MS 39402-1000 | |
| (601) 450-0521 | |
| (601) 450-0554 |
| Full Name | Dr Steven M Murphey |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 40 Years |
| Location | 5000 W 4th St, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669400495 | NPI | - | NPPES |
| 00116073 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 12065 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Highland Community Hospital | Picayune, MS | Hospital |
| Merit Health Wesley | Hattiesburg, MS | Hospital |
| Magee General Hospital | Magee, MS | Hospital |
| Wayne General Hospital | Waynesboro, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comprehensive Radiology Services, Pllc | 1759364946 | 23 |
| Hattiesburg Clinic, Pa | 5193706794 | 489 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Students at Louisiana State University today heard an executive with Baton Rouge-based Amedisys talk about how quality is measured in health care and why it should matter to all Americans. Amedisys is the largest home health care and hospice company in the U.S., providing care to more than 35,000 patients every day.
CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. James's University Hospital in Leeds, United Kingdom (UK).
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
Like the hairs they resemble, cilia come in all lengths, from short to long. But unlike the hair on our heads, the length of sensory cilia on nerve cells in our noses is of far more than merely cosmetic significance. A team of researchers from the Perelman School of Medicine at the University of Pennsylvania found a location-dependent pattern in cilia length in the mouse nasal cavity that affects sensitivity to odors.
› Verified 3 days ago
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Students at Louisiana State University today heard an executive with Baton Rouge-based Amedisys talk about how quality is measured in health care and why it should matter to all Americans. Amedisys is the largest home health care and hospice company in the U.S., providing care to more than 35,000 patients every day.
CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. James's University Hospital in Leeds, United Kingdom (UK).
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
Like the hairs they resemble, cilia come in all lengths, from short to long. But unlike the hair on our heads, the length of sensory cilia on nerve cells in our noses is of far more than merely cosmetic significance. A team of researchers from the Perelman School of Medicine at the University of Pennsylvania found a location-dependent pattern in cilia length in the mouse nasal cavity that affects sensitivity to odors.
› Verified 3 days ago
| Entity Name | Comprehensive Radiology Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992731590 PECOS PAC ID: 1759364946 Enrollment ID: O20040609000828 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Students at Louisiana State University today heard an executive with Baton Rouge-based Amedisys talk about how quality is measured in health care and why it should matter to all Americans. Amedisys is the largest home health care and hospice company in the U.S., providing care to more than 35,000 patients every day.
CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. James's University Hospital in Leeds, United Kingdom (UK).
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
Like the hairs they resemble, cilia come in all lengths, from short to long. But unlike the hair on our heads, the length of sensory cilia on nerve cells in our noses is of far more than merely cosmetic significance. A team of researchers from the Perelman School of Medicine at the University of Pennsylvania found a location-dependent pattern in cilia length in the mouse nasal cavity that affects sensitivity to odors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven M Murphey, MD 5000 W 4th St, Hattiesburg, MS 39402-1000 Ph: (601) 450-0521 | Dr Steven M Murphey, MD 5000 W 4th St, Hattiesburg, MS 39402-1000 Ph: (601) 450-0521 |
News Archive
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Students at Louisiana State University today heard an executive with Baton Rouge-based Amedisys talk about how quality is measured in health care and why it should matter to all Americans. Amedisys is the largest home health care and hospice company in the U.S., providing care to more than 35,000 patients every day.
CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. James's University Hospital in Leeds, United Kingdom (UK).
The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.
Like the hairs they resemble, cilia come in all lengths, from short to long. But unlike the hair on our heads, the length of sensory cilia on nerve cells in our noses is of far more than merely cosmetic significance. A team of researchers from the Perelman School of Medicine at the University of Pennsylvania found a location-dependent pattern in cilia length in the mouse nasal cavity that affects sensitivity to odors.
› Verified 3 days ago
Dr. Craig S Howard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Dr. Cleveland Alexander Hudson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Dr. Sophy H Mangana, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-1700 Fax: 601-288-1715 | |
Dr. Naim Joseph Salloum, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-1700 Fax: 601-288-1715 | |
Dr. Neil J Solomon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Dr. Richard F Mccarthy, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 Fax: 601-450-0554 | |
Steven G Cunningham, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 4th St, Hattiesburg, MS 39402 Phone: 601-450-0521 |